Menu

TC Biopharm (Holdings) Plc TCBP

Full chart Compare
Set alert

Price alert · TCBP

All alert types
0.50 USD 0.00 (+0.00%)

At closeMar 21, 2025, 4:00 PM EDT

0.50 Day range 1.51
0.436 52-week range 41.50
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Operating Income → Expenses: $16.21MExpenses → Selling, General & Admin: $8.74MExpenses → Research & Development: $7.59MExpenses → Other Expenses: $6.75MIncome Tax Benefit → Expenses: $1.72MGross Profit → Expenses: $3.84MRevenue → Gross Profit: $3.84MNet Loss → Expenses: $1.31MOther Operating Income$16.21MIncome Tax Benefit$1.72MGross Profit$3.84MNet Loss$1.31MExpenses$23.08MSelling, General & Admin$8.74MResearch & Development$7.59MOther Expenses$6.75MRevenue$3.84M

Latest period ending Dec 31, 2023 · select a line to chart its full history

TCBP annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-14.24M-12.08M-7.28M-6.34M-6.64M
-5.91M-1.31M-13.58M-5.46M-6.07M
-3,072.00-6,112.00-111,232.00-46,144.00-54,400.00
TCBP annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.46M4.81M1.57M748.01K956.50K
8.93M11.29M8.02M7.27M10.14M
6.25M10.96M24.58M10.61M12.68M
1.80M2.78M16.63M3.03M3.44M
2.69M331.26K-16.56M-3.35M-2.54M
TCBP annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-10.54M-15.29M-6.51M-4.38M-6.64M
-208.79K-310.20K-143.22K-204.99K-2.20M
8.52M18.65M6.53M3.43M3.27M
-110.35K-185.71K-20.03K-34.90K-2.03M
-2.35M3.24M800.89K-206.59K-5.65M